K. F. Rabe (Leiden, The Netherlands), H. Milgrom (Denver, United States of America)
A comparison of suplatast tosilate, a Th2 cytokine inhibitor, and inhaled fluticasone propionate for airway inflammation in mild asthma J. Tamaoki, K. Isono, M. Kondo, T. Takizawa, A. Nagai (Tokyo, Kurihashi, Japan)
| |
Anti-inflammatory properties of nimesulide and clarithromycin: a comparative study during the therapy of bronchial sepsis involving P.aeruginosa G. V. Shmarina, A. L. Pukhalsky, S. N. Kokarovtseva, N. I. Kapranov, L. A. Shabalova (Moscow, Russia)
| |
The effect of heparin nebulization on BAL cellularity and clinical evaluation in a long-time study in patients with bronchial asthma A. M. Fal, M. Krasnowska, J. Miecielica, A. Kwasniewski, A. Obojski, J. Malolepszy (Wroclaw, Poland)
| |
Study of the Glutoxim-containing inhalation treatment in bronchial asthma patients M. A. Zaitseva, L. A. Kozhemyakin, T. E. Gembitskaya, A. V. Molodtsova (St-Petersburg, Russia)
| |
Efficacy and long-term safety of ciclesonide in asthmatic patients as demonstrated in a 52 week long study K. R. Chapman, P. Patel, L. P. Boulet, A. D. D'Urzo, M. Alexander, S. Mehra, C. Oedekoven (Toronto, Mississauga, Sainte-Foy, Niagara Falls, Oshawa, Canada; Konstanz, Germany)
| |
Oral theophylline benefits stable 'irreversible' chronic obstructive pulmonary disease: a systematic review and meta-analysis F. S. F. Ram, S. Cendon (London, United Kingdom; Sau Paulo, Brazil)
| |
Roflumilast, a new orally active phosphodiesterase 4 inhibitor, is effective in the treatment of chronic obstructive pulmonary disease D. Bredenbröker, J. Syed, S. Leichtl, F. Rathgeb, W. Wurst (Konstanz, Germany)
| |
N-acetylcysteine for the treatment of acute exacerbations of COPD P. N. Black, A. Morgan-Day, T. E. Picton, P. J. Poole, R. P. Young, J. Stewart (Auckland, New Zealand)
| |